Select your products and services :
Select your country :
Americas
Europe
Asia and South Pacific
Middle East and Africa

Update your choices | BU : GMP BioManufacturing | Country : USA

Analytical Method Lifecycle

Roadmap for Biopharmaceutical Development

Abstract

Analytical method lifecycle is a continuous process that improves and documents the understanding of the capabilities of each analytical method used throughout the clinical development of a new drug candidate.

Of key importance, analytical lifecycle-related activities have to be appropriately staged in accordance with the regulatory requirements without neglecting the financial and time constraints incurred by each project. Currently, regulatory requirements for analytical methods are primarily directed at prerequisites for commercial manufacturing, the end point of the development process, without any description of requirements regarding the stepwise development leading to validation.

This article proposes an analytical lifecycle roadmap that will stage the various steps involved in analytical method development while attempting to meet the expectations of the stakeholders involved in the management of project risk, development costs, and regulatory compliance.

Parts

  • Regulatory foundations
  • Preparing analytical method validation
  • Steps in analytical method qualification
  • Analytical method validation and postvalidation
  • The analytical lifecycle roadmap

All White Papers and Technical Guides - GMP BioManufacturing



White Papers and Technical Guides - GMP BioManufacturing

Discover all our White Papers and Technical Guides related to biopharmaceutical drug development.


We use cookies to ensure the best experience on our website. By continuing to use this website, you consent to our cookie policy.